Inhibrx Biosciences, Inc. (INBX)
Healthcare
Biotechnology
82.10 $
-3.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Inhibrx Biosciences, Inc. (INBX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -38 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -42 | -54 | -57 | -63 | -57 | -30 | -44 | -36 | -30 | -34 | -30 | -38 | -132 | |
| 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.8 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | 2.3 | |
| 7.2 | 6.5 | 6.4 | 6.4 | 48 | 3.0 | 3.0 | 2.5 | 2.8 | 3.2 | 2.7 | 2.7 | 11 | |
| -3.4 | -11 | 25 | 7.2 | 35 | 9.4 | 0.0 | 3.3 | -5.8 | -3.4 | -1.7 | -9.0 | -20 | |
| 0.3 | 0.8 | 3.4 | 1.1 | 1.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.3 | -0.8 | -3.4 | -1.1 | -1.2 | -0.2 | 0.0 | 0.0 | – | 0.0 | – | – | – | |
| – | – | – | – | – | 0.0 | – | 100 | 0.0 | 0.0 | 0.0 | 75 | 75 | |
| 0.9 | 200 | 0.9 | 39 | 33 | 2.7 | 0.0 | 100 | 0.0 | 0.4 | 1.3 | 75 | 77 | |
| 192 | 145 | -59 | -25 | -26 | -31 | -44 | 64 | -30 | -33 | -29 | 37 | -55 | |
| -43 | -55 | -60 | -64 | -59 | -31 | -44 | -36 | -30 | -34 | -30 | -38 | -132 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.